Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.

dc.contributor.authorGriñán Ferré, Christian
dc.contributor.authorJarne Ferrer, Júlia
dc.contributor.authorBellver Sanchis, Aina
dc.contributor.authorRibalta Vilella, Marta
dc.contributor.authorBarroso Fernández, Emma
dc.contributor.authorSalvador, Jesús M.
dc.contributor.authorJurado Aguilar, Javier
dc.contributor.authorPalomer Tarridas, Francesc Xavier
dc.contributor.authorVázquez Carrera, Manuel
dc.contributor.authorPallàs i Llibería, Mercè, 1964-
dc.date.accessioned2024-04-16T07:38:42Z
dc.date.available2024-04-16T07:38:42Z
dc.date.issued2024-02-23
dc.date.updated2024-04-16T07:38:47Z
dc.description.abstract<p><em>Gadd45 genes have been implicated in survival mechanisms, including apoptosis, autophagy,</em></p><p><em>cell cycle arrest, and DNA repair, which are processes related to aging and life span. Here, we</em></p><p><em>analyzed if the deletion of Gadd45a activates pathways involved in neurodegenerative disorders such</em></p><p><em>as Alzheimer’s Disease (AD). This study used wild-type (WT) and Gadd45a knockout (Gadd45a−/−)</em></p><p><em>mice to evaluate AD progression. Behavioral tests showed that Gadd45a−/− mice presented lower</em></p><p><em>working and spatial memory, pointing out an apparent cognitive impairment compared with WT</em></p><p><em>animals, accompanied by an increase in Tau hyperphosphorylation and the levels of kinases involved</em></p><p><em>in its phosphorylation in the hippocampus. Moreover, Gadd45a−/− animals significantly increased the</em></p><p><em>brain’s pro-inflammatory cytokines and modified autophagy markers. Notably, neurotrophins and</em></p><p><em>the dendritic spine length of the neurons were reduced in Gadd45a−/− mice, which could contribute</em></p><p><em>to the cognitive alterations observed in these animals. Overall, these findings demonstrate that the</em></p><p><em>lack of the Gadd45a gene activates several pathways that exacerbate AD pathology, suggesting that</em></p><p><em>promoting this protein’s expression or function might be a promising therapeutic strategy to slow</em></p><p><em>down AD progression.</em></p>
dc.format.extent1 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec747771
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/2445/210000
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofInternational Journal of Molecular Sciences, 2024
dc.rightscc-by (c) Griñán-Ferré C et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationMalaltia d'Alzheimer
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationEpigenètica
dc.subject.otherAlzheimer's disease
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherEpigenetics
dc.titleDeletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
858356.pdf
Mida:
3.77 MB
Format:
Adobe Portable Document Format